Staff Writer
The Iowa drug developer is backed by Dewaay Capital Management
The online marketplace provider held the largest VC-backed IPO in April with a $266.7 million offering
The San Diego-based biotech company held a $76.8 million IPO
The drug developer is backed by InterWest and Alta
The Cambridge, Mass.-based company was one of five venture-backed life science companies to debut in April
The company, which operates a group buying website, counts Goldman Sachs as a backer
The API software company raised fudning from Norwest, Bay Partners and Sapphie, among others
The drug developer raised venture funding from Johnson & Johnson and OrbiMed, among others
French firm is targeting to raise $126 million for the growing and nascent microbiome sector
Deals, M&A and IPOs all take steps forward in the month